Target intelligence / Profile preview

Cyclin-dependent kinase-like 2 (CDKL2)

Target
CDKL2
Molecular classification
Enzyme, Serine/threonine protein kinase, CDC2-related kinase family
01

Overview

Cyclin-dependent kinase-like 2 is a CDC2-related serine/threonine protein kinase encoded by the CDKL2 gene in humans. The protein accumulates primarily in the cytoplasm, with lower levels detected in the nucleus. It is classified as part of a large family of protein kinases structurally related to cyclin-dependent kinases but is considered a distinct entity. While it possesses protein kinase activity, specific biological functions and disease associations are less well-characterized compared to classical CDKs such as CDK1 or CDK2. CDKL2 is not synonymous with CDK2 or classical cyclin-dependent kinases, though they share similarity in sequence and domain architecture. The correct canonical name is Cyclin-dependent kinase-like 2 (CDKL2). It is an enzyme, specifically a serine/threonine kinase, belonging to the CDC2-related protein kinase family. Its biological role is phosphorylation of protein substrates, potentially affecting cellular signaling and possibly cell cycle regulation, but the specifics are not well established in public domain sources. There are no reported drugs, biomarkers, or major toxicology concerns linked to CDKL2 as of the information available in current search results.

Other names
cyclin-dependent kinase like 2CDKL2
02

Biological functions

Protein phosphorylationRegulation of cellular signalingPossible role in cell cycle and cytoplasmic processes

Beyond the preview

Go deeper on Cyclin-dependent kinase-like 2 (CDKL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin-dependent kinase-like 2 (CDKL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call